» Authors » Chris Kosmidis

Chris Kosmidis

Explore the profile of Chris Kosmidis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 56
Citations 942
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Wang R, Eades C, Palmer M, Platt G, Fowler S, Kosmidis C
Med Mycol . 2023 Jul; 61(8). PMID: 37491704
Allergic fungal airway diseases are associated with asthma exacerbations and poor control. However, the early identification of allergic Aspergillus airway diseases can be challenging, especially in resource-poor countries. We aimed...
12.
Rozaliyani A, Antariksa B, Nurwidya F, Zaini J, Setianingrum F, Hasan F, et al.
Life (Basel) . 2023 Apr; 13(4). PMID: 37109545
The heterogeneity of the lung microbiome and its alteration are prevalently seen among chronic lung diseases patients. However, studies to date have primarily focused on the bacterial microbiome in the...
13.
Armstrong-James D, Kosmidis C, Bromley M
Curr Opin Infect Dis . 2023 Mar; 36(2):146-151. PMID: 36912585
Purpose Of Review: Chronic pulmonary aspergillosis is a major global infection in individuals with preexisting structural lung diseases and those with immunodeficiencies, in particular cytokine defects. Current treatment options are...
14.
Ocansey B, Otoo B, Gbadamosi H, Afriyie-Mensah J, Opintan J, Kosmidis C, et al.
J Fungi (Basel) . 2023 Jan; 9(1). PMID: 36675847
Chronic pulmonary aspergillosis (CPA) often occurs in patients that have been previously treated for pulmonary tuberculosis (PTB). A limited number of studies have looked at the development of CPA at...
15.
Otu A, Kosmidis C, Mathioudakis A, Ibe C, Denning D
Infection . 2023 Jan; 51(4):813-829. PMID: 36662439
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. In this review, we present the clinical spectrum and pathogenesis of syndromes caused by Aspergillus in COPD...
16.
Sprute R, Van Braeckel E, Flick H, Hoenigl M, Kosmidis C, Agarwal R, et al.
J Antimicrob Chemother . 2022 Nov; 78(1):225-231. PMID: 36374549
Background: Chronic pulmonary aspergillosis (CPA) can complicate underlying pulmonary diseases, and clinical management of CPA is challenging. Guidelines support clinicians but due to the complexity of the disease they can...
17.
Ocansey B, Otoo B, Adjei A, Gbadamosi H, Kotey F, Kosmidis C, et al.
Med Mycol . 2022 Aug; 60(9). PMID: 35953428
Chronic pulmonary aspergillosis (CPA) may mimic pulmonary tuberculosis (PTB). The two diseases are clinically indistinguishable and may result in CPA misdiagnosed as PTB or vice versa. Although PTB is largely...
18.
Amona F, Oladele R, Resendiz-Sharpe A, Denning D, Kosmidis C, Lagrou K, et al.
Med Mycol . 2022 Jul; 60(8). PMID: 35906879
Lay Summary: Emergence of triazole resistance has been observed in Aspergillus fumigatus. TRAF was found from environmental (17.1%) and clinical (1.3%) settings in Africa. We highlighted that triazole resistance in...
19.
Kosmidis C
J Fungi (Basel) . 2022 Jul; 8(7). PMID: 35887469
I would like to thank all authors who contributed to this Special Issue on Chronic Pulmonary Aspergillosis (CPA) [...].
20.
Ocansey B, Otoo B, Asamoah I, Ganu V, Berko K, Oladele O, et al.
Open Forum Infect Dis . 2022 Jul; 9(7):ofac277. PMID: 35854987
Background: Cryptococcal meningitis (CM) and disseminated histoplasmosis (DH) are common in people with human immunodeficiency virus (PWH) and diagnosed by detecting cryptococcal antigen (CrAg) and antigen (HistoAg), respectively. In Ghana,...